Top compounds associated with response to DOK2


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC 0.33 5e-20
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.31 2e-18
mRNA linifanib GDSC1000 pan-cancer AAC 0.33 8e-18
mRNA AC220 GDSC1000 pan-cancer AAC 0.31 2e-16
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.3 7e-16
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.27 2e-12
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA linifanib CTRPv2 pan-cancer AAC 0.22 5e-09
mRNA ATRA GDSC1000 pan-cancer AAC 0.22 5e-09
Download CSV